Transcript of Hallek Interview Part 3: Clinical Trials in CLL
Created Date: July 07, 2009
Description: Dr. Michael Hallek discusses the benefits and challenges of using mouse models such as TCL1, NOD/SCID, and NZB in CLL drug trials and studies attempting to isolate potential cancer stem cells. Then, he discusses proposed trials comparing the effectiveness of various drug combinations and, hypothetically, how one might develop a study to determine whether certain types of chemical agents are linked to CLL.
Creator: Gerald Marti
Contributor: Michael Hallek
Identifier: Hallek03_research
Subject: Clinical Research, Treatment
Related: Hallek01_collaboration, Hallek02_treatment
Series: Hallek Oral Histories
Type: Video
Rights: This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CLL Digital Archive 